Functional role for cannabinoids in respiratory stability during sleep

Sleep

Volumn 25, Issue 4, 2002, Pages 391-398

  Carley, David W ^a   Pavlovic, Sasa ^a   Janelidze, Marika ^a   Radulovacki, Miodrag ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR AGONIST; OLEAMIDE; SEROTONIN; SEROTONIN RECEPTOR; TETRAHYDROCANNABINOL; ENDOCANNABINOID;

ARTICLE; CONTROLLED STUDY; MALE; NERVE CELL; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RAT; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; ANIMAL; BREATHING; CROSSOVER PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; METHODOLOGY; REM SLEEP; SCALP; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TIME; WAKEFULNESS;

ANIMALS; CANNABINOIDS; CROSS-OVER STUDIES; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENDOCANNABINOIDS; MALE; MUSCLE, SKELETAL; POLYSOMNOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION; SCALP; SLEEP APNEA SYNDROMES; SLEEP, REM; TIME FACTORS; WAKEFULNESS;

EID: 0037096056     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/25.4.388     Document Type: Article

References (36)

1. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528
2. Towards cannabinoid drugs - Revisited
3. Chemical characterization of a family of brain lipids that induce sleep
4. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist
5. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
6. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
7. Mechanism of the hypotensive action of anandamide in anesthetized rats
8. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
9. Role of peripheral serotonin in the regulation of central sleep apneas in rats
10. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat
11. Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rats
12. The effects of ondansetron on sleep-disordered breathing in the English bulldog
13. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors
14. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
15. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor
16. Rem Sleep apnea
17. Practical implementation of the barometric method for measurement of tidal volume
18. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
19. Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans
20. Oleamide: An endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules
21. Sleep apnea and quality of life
22. Periodic breathing and the pathogenesis of occlusive sleep apneas
23. Treatment of refractory sleep apnea with supplemental carbon dioxide
24. Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure
25. Alteration in obstructive apnea pattern induced by changes in oxygen and carbon-dioxide concentrations
26. Hypersomnia with periodic apneas
27. Effects of inspired gas on sleep-related apnea in the rat
28. Relative stability of human respiration during progressive hypoxia
29. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic?
30. Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors
31. Modulation of respiratory activity of neonatal rat phrenic motoneurones by serotonin
32. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors
33. Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide
34. Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling